A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease

Summary

The purpose of this study is to assess the safety, tolerability, pharmacokinetic, and efficacy of surovatamig administered by subcutaneous injection in adult participants with primary membranous nephropathy.

Timeline

Start

2026-03-28

Primary completion

2028-04-24

Completion

2029-10-15

Drugs

Indications